# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA832521 | Functional | Cytotoxicity against camptothecin-resistant RPMI 8402 | Homo sapiens | 23 | ALA1142652 | cell-based format | Scientific Literature | |
2. | ALA834302 | Functional | Inhibitory concentration against KB/V-1 cells overexpress MDR1 | Homo sapiens | 23 | ALA1142652 | cell-based format | Scientific Literature | |
3. | ALA835225 | Functional | Inhibitory concentration against KBH5.0 cells overexpress BCRP | Homo sapiens | 23 | ALA1142652 | cell-based format | Scientific Literature | |
4. | ALA834674 | Functional | Inhibitory concentration against KB3-1 cell line was determined | Homo sapiens | 23 | ALA1142652 | cell-based format | Scientific Literature | |
5. | ALA825079 | Functional | Inhibitory concentration against P388 cell line in mouse leukemia was determine | Mus musculus | 23 | ALA1142652 | cell-based format | Scientific Literature | |
6. | ALA825082 | Functional | Inhibitory concentration against lymphoblast RPMI 8402 cell line was determined | Homo sapiens | 23 | ALA1142652 | cell-based format | Scientific Literature | |
7. | ALA834496 | Functional | Inhibitory concentration against camptothecin-resistant variant of P388 cell line was determined | Mus musculus | 23 | ALA1142652 | cell-based format | Scientific Literature | |
8. | ALA836629 | Functional | Relative topoisomerase I-mediated plasmid DNA cleavage compared to topotecan | Homo sapiens | 22 | ALA1142652 | assay format | Scientific Literature | |
9. | ALA3073879 | Functional | Cytotoxicity against Mus musculus (mouse) P388 cells assessed as growth inhibition | Mus musculus | 22 | ALA3046006 | cell-based format | Scientific Literature | |
10. | ALA4303805 | Functional | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging | Homo sapiens | 5,612 | ALA4303101 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | |
11. | ALA4495582 | Functional | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | ALA4495564 | assay format | SARS-CoV-2 Screening Data 2020-21 | |
12. | ALA4513082 | Functional | Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging | Chlorocebus sabaeus | 7,212 | ALA4495565 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | |
13. | ALA4808149 | Binding | Enzymatic assay of human HDAC6 with commercial peptide substrate | Homo sapiens | 5,603 | ALA4808148 | single protein format | Fraunhofer HDAC6 | |
14. | ALA4808150 | Binding | Enzymatic assay of human HDAC6 with custom peptide substrate | Homo sapiens | 5,603 | ALA4808148 | single protein format | Fraunhofer HDAC6 |